Physician profile
Riza Seit
NPI 1003173212
$1,712.32
in general payments reported to CMS, 2019-2025
11 companies · $909 in 2025
The $909 reported for 2025 was more than what 84% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $37.43 · 2022: $41.82 · 2023: $292 · 2024: $432 · 2025: $909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,633.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $522.70 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $488.38 | 2025 | Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Terumo Medical Corporation | $227.73 | 2020-2025 | Azur Cx Detachable |
| Boston Scientific Corporation | $227.09 | 2023-2024 | Embold Fibered |
| Angiodynamics, INC. | $90.24 | 2024-2025 | Alphavac |
| Abbott Laboratories | $47.15 | 2025 | Diamondback Coronary, Xience Skypoint |
| Medtronic, INC. | $28.94 | 2025 | Spiderfx |
| Novartis Pharmaceuticals Corporation | $26.86 | 2025 | |
| Imperative Care, INC | $21.43 | 2025 | Symphony Catheter |
| Merck Sharp & Dohme LLC | $17.57 | 2025 | Verquvo |
| Cardiva Medical, INC. | $14.23 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riza Seit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.